{"id":"adrenocorticotrophic-hormone","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Hypokalemia"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Fluid retention"},{"rate":null,"effect":"Mood changes"}]},"_chembl":{"chemblId":"CHEMBL2108078","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"ACTH is a peptide hormone that binds to melanocortin-2 receptors on adrenocortical cells, triggering a cascade that increases synthesis and secretion of glucocorticoids (cortisol), mineralocorticoids (aldosterone), and adrenal androgens. This endogenous hormone replacement or supplementation approach restores or enhances the hypothalamic-pituitary-adrenal (HPA) axis function in conditions of adrenal insufficiency or immune dysregulation.","oneSentence":"Adrenocorticotrophic hormone (ACTH) stimulates the adrenal cortex to produce and release cortisol and other corticosteroids.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:59:56.560Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Adrenocortical insufficiency"},{"name":"Infantile spasms (West syndrome)"},{"name":"Autoimmune and inflammatory conditions"}]},"trialDetails":[{"nctId":"NCT03708900","phase":"PHASE2","title":"Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome","status":"RECRUITING","sponsor":"RECORDATI GROUP","startDate":"2021-04-28","conditions":"Cushing Syndrome","enrollment":12},{"nctId":"NCT02683889","phase":"PHASE3","title":"Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2019-02-01","conditions":"FSGS","enrollment":15},{"nctId":"NCT07460232","phase":"EARLY_PHASE1","title":"FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-04","conditions":"Cushing Disease, Pituitary Adenoma","enrollment":50},{"nctId":"NCT07005154","phase":"PHASE2","title":"A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer","status":"RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2025-06-19","conditions":"Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer","enrollment":218},{"nctId":"NCT06825390","phase":"NA","title":"AuriculoTherapy NeuroImaging","status":"RECRUITING","sponsor":"Keith M Vogt","startDate":"2025-07-30","conditions":"Low Back Pain, Chronic Low-back Pain, Back Pain, Low","enrollment":60},{"nctId":"NCT06815471","phase":"PHASE2","title":"CRF2 Agonist for the Treatment of Worsening Heart Failure","status":"RECRUITING","sponsor":"Corteria Pharmaceuticals","startDate":"2025-08-07","conditions":"Worsening Heart Failure","enrollment":300},{"nctId":"NCT02541955","phase":"PHASE4","title":"Use of Acthar in Rheumatoid Arthritis (RA) Related Flares","status":"COMPLETED","sponsor":"Veena Ranganath, MD, MS","startDate":"2017-07-20","conditions":"Rheumatoid Arthritis (RA)","enrollment":40},{"nctId":"NCT04266587","phase":"NA","title":"ACTH Stability on Whole Blood","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2021-11-18","conditions":"ACTH","enrollment":10},{"nctId":"NCT07350031","phase":"","title":"Serum and Salivary Cortisol Assessment in Patients With Adrenal Incidentalomas and Healthy Controls","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2016-11-24","conditions":"Adrenal Incidentaloma, Hypercortisolism","enrollment":209},{"nctId":"NCT06344143","phase":"","title":"Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2024-11-20","conditions":"Mild Autonomous Cortisol Secretion (MACS)","enrollment":20},{"nctId":"NCT00227253","phase":"","title":"Chromosome 18 Clinical Research Center","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"1993-09","conditions":"Chromosome Aberrations, Growth Hormone Deficiency, Hypomyelination","enrollment":4000},{"nctId":"NCT06336356","phase":"PHASE2","title":"A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-06-10","conditions":"Uncontrolled Hypertension","enrollment":48},{"nctId":"NCT02931175","phase":"PHASE2","title":"ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)","status":"COMPLETED","sponsor":"Quan Dong Nguyen","startDate":"2017-11-10","conditions":"Uveitis","enrollment":28},{"nctId":"NCT04546126","phase":"EARLY_PHASE1","title":"Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)","status":"RECRUITING","sponsor":"Benjamin Viglianti","startDate":"2021-11-01","conditions":"Radiotracer, Hypertension, Cholesterol","enrollment":24},{"nctId":"NCT02339506","phase":"NA","title":"Stress and the Nervous System","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2015-04","conditions":"Autonomic Nervous System, Baroreflex, Stress, Physiological","enrollment":23},{"nctId":"NCT05307328","phase":"PHASE2","title":"SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome","status":"COMPLETED","sponsor":"Sparrow Pharmaceuticals","startDate":"2022-09-01","conditions":"Cushing's Syndrome I, Cushing Disease Due to Increased ACTH Secretion, Cortisol Excess","enrollment":26},{"nctId":"NCT06740838","phase":"","title":"Overnight Dexamethasone in Primary Aldosteronism Screening","status":"RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2024-10-22","conditions":"Primary Aldosteronism, Hypertension","enrollment":240},{"nctId":"NCT05907291","phase":"PHASE2","title":"Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)","status":"COMPLETED","sponsor":"Crinetics Pharmaceuticals Inc.","startDate":"2023-07-03","conditions":"Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia","enrollment":38},{"nctId":"NCT06712823","phase":"PHASE2","title":"An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894","status":"RECRUITING","sponsor":"Crinetics Pharmaceuticals Inc.","startDate":"2025-02-25","conditions":"Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia","enrollment":150},{"nctId":"NCT05703425","phase":"PHASE2","title":"The Effect of Sulfasalazine on CRH Levels in Pregnant Women","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2023-03-01","conditions":"Preterm Birth","enrollment":50},{"nctId":"NCT04037605","phase":"EARLY_PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2020-02-09","conditions":"Sleep Restriction","enrollment":5},{"nctId":"NCT03142893","phase":"PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peter y. Liu","startDate":"2017-05-08","conditions":"Sleep Restriction","enrollment":80},{"nctId":"NCT04308590","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2020-07-27","conditions":"Hypercortisolism","enrollment":137},{"nctId":"NCT02813655","phase":"PHASE2","title":"Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)","status":"TERMINATED","sponsor":"Hospices Civils de Lyon","startDate":"2016-10","conditions":"Post-dural Puncture Headache","enrollment":46},{"nctId":"NCT05293366","phase":"","title":"LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":"Long Covid-19","enrollment":100},{"nctId":"NCT05012072","phase":"NA","title":"Reducing Pregnancy Risks: The Mastery Lifestyle Intervention","status":"RECRUITING","sponsor":"Microgen LLC","startDate":"2021-08-01","conditions":"Mental Health Wellness 1, Preterm Birth","enrollment":238},{"nctId":"NCT03697109","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2018-11-15","conditions":"Cushing Syndrome","enrollment":152},{"nctId":"NCT05008146","phase":"EARLY_PHASE1","title":"Imaging CRF X NOP Interactions in CUD","status":"RECRUITING","sponsor":"Rajesh Narendran","startDate":"2020-12-31","conditions":"Cocaine Use Disorder","enrollment":80},{"nctId":"NCT07003334","phase":"","title":"Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer","status":"RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2025-01-03","conditions":"Gastric Cancers","enrollment":268},{"nctId":"NCT06962202","phase":"","title":"Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2022-08-15","conditions":"Cushing Syndrome","enrollment":100},{"nctId":"NCT06964269","phase":"PHASE4","title":"Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease","status":"RECRUITING","sponsor":"Toyos Clinic","startDate":"2025-02-11","conditions":"Autoimmune Diseases, Dry Eye, Neurotrophic Keratitis","enrollment":20},{"nctId":"NCT04202094","phase":"NA","title":"Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems","status":"ENROLLING_BY_INVITATION","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2020-09-08","conditions":"Childhood Cancer, Hematological Disorders","enrollment":50},{"nctId":"NCT02226341","phase":"PHASE4","title":"ACTHar in the Treatment of Lupus Nephritis","status":"TERMINATED","sponsor":"Columbia University","startDate":"2014-10","conditions":"Lupus Nephritis","enrollment":8},{"nctId":"NCT06825182","phase":"PHASE3","title":"Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-11-07","conditions":"Type 2 Diabetes Mellitus","enrollment":1000},{"nctId":"NCT01950234","phase":"PHASE2","title":"ACTH in Progressive Forms of MS","status":"TERMINATED","sponsor":"University of Minnesota","startDate":"2014-04-17","conditions":"Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis","enrollment":59},{"nctId":"NCT06259227","phase":"NA","title":"Cardiorespiratory Fitness Training in Patients with Incomplete Spinal Cord Injury","status":"RECRUITING","sponsor":"Sint Maartenskliniek","startDate":"2024-01-11","conditions":"Incomplete Spinal Cord Injury, Exercise Training","enrollment":32},{"nctId":"NCT04642391","phase":"","title":"Defining the Mechanisms Underlying Adrenal Insufficiency in Cirrhosis","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2021-08-02","conditions":"Cirrhosis, Adrenal Insufficiency","enrollment":76},{"nctId":"NCT04234867","phase":"PHASE1","title":"Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)","status":"TERMINATED","sponsor":"Kinderkrankenhaus auf der Bult","startDate":"2022-05-18","conditions":"Type 1 Diabetes, Diabetic Ketoacidosis","enrollment":2},{"nctId":"NCT03514589","phase":"PHASE2","title":"NeSST2: The Development of a Noninvasive Short Synacthen Test","status":"RECRUITING","sponsor":"Sheffield Children's NHS Foundation Trust","startDate":"2012-10-12","conditions":"Adrenal Suppression","enrollment":12},{"nctId":"NCT06611449","phase":"NA","title":"The Effect of Minimal Flow Anesthesia on Oxidative and Neuroendocrine Stress Response","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bezmialem Vakif University","startDate":"2024-06-30","conditions":"Low Flow Anesthesia, Oxidative Stress, Neuroinflammatory Response","enrollment":2},{"nctId":"NCT05071781","phase":"PHASE4","title":"Effect of CRH on Duodenal Markers and Gastric Sensorimotor Function","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2021-05-21","conditions":"GI Motility Disorder","enrollment":20},{"nctId":"NCT05279118","phase":"PHASE2, PHASE3","title":"Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2022-04-18","conditions":"Ketogenic Diet, West Syndrome, Infantile Spasm","enrollment":80},{"nctId":"NCT02245841","phase":"PHASE4","title":"Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2015-06-15","conditions":"Dermatomyositis, Juvenile Dermatomyositis","enrollment":19},{"nctId":"NCT03021317","phase":"PHASE4","title":"Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2016-12-20","conditions":"Multiple Sclerosis","enrollment":5},{"nctId":"NCT05696613","phase":"PHASE3","title":"A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy","status":"RECRUITING","sponsor":"Cerium Pharmaceuticals, Inc.","startDate":"2023-03-13","conditions":"Primary Membranous Nephropathy","enrollment":148},{"nctId":"NCT02818660","phase":"NA","title":"Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests","status":"COMPLETED","sponsor":"Haukeland University Hospital","startDate":"2016-05-21","conditions":"Adrenal Insufficiency","enrollment":232},{"nctId":"NCT03511625","phase":"PHASE3","title":"The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Attune Health Research, Inc.","startDate":"2018-10-02","conditions":"Rheumatoid Arthritis","enrollment":6},{"nctId":"NCT04461535","phase":"NA","title":"Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism(ADOPA)","status":"COMPLETED","sponsor":"Chongqing Medical University","startDate":"2020-07-08","conditions":"Primary Aldosteronism","enrollment":228},{"nctId":"NCT02725177","phase":"NA","title":"Ocular Sarcoidosis Open Label Trial of ACTHAR Gel","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2016-07","conditions":"Ocular Sarcoidosis, Panuveitis, Anterior Uveitis","enrollment":9},{"nctId":"NCT03905603","phase":"EARLY_PHASE1","title":"Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2019-10-08","conditions":"Polycystic Ovary Syndrome","enrollment":144},{"nctId":"NCT01421797","phase":"NA","title":"Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2006-10-10","conditions":"Hyperandrogenemia, Polycystic Ovary Syndrome, Obesity","enrollment":84},{"nctId":"NCT03465111","phase":"PHASE2","title":"A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis","status":"UNKNOWN","sponsor":"Metropolitan Eye Research & Surgery Institute","startDate":"2019-01-01","conditions":"Scleritis","enrollment":30},{"nctId":"NCT06079788","phase":"PHASE3","title":"Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized，Open-label Clinical Trial.","status":"RECRUITING","sponsor":"Mao Jianhua","startDate":"2023-11-01","conditions":"Nephrotic Syndrome in Children","enrollment":140},{"nctId":"NCT06075992","phase":"NA","title":"Massage Application and Motor Performance, Stress Assessment in Premature Babies","status":"UNKNOWN","sponsor":"Mustafa Kemal University","startDate":"2024-01-20","conditions":"Infant, Premature Birth","enrollment":30},{"nctId":"NCT06048887","phase":"PHASE1","title":"Single and Multiple-Ascending Dose Study of CRN04894 in Healthy Volunteers","status":"COMPLETED","sponsor":"Crinetics Pharmaceuticals Inc.","startDate":"2020-12-18","conditions":"Healthy Volunteers","enrollment":88},{"nctId":"NCT02030028","phase":"NA","title":"ACTH Gel Therapy in Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Dana Ascherman","startDate":"2014-11","conditions":"Rheumatoid Arthritis","enrollment":18},{"nctId":"NCT03727776","phase":"EARLY_PHASE1","title":"Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2019-08-19","conditions":"Proliferative Vitreoretinopathy","enrollment":11},{"nctId":"NCT02523092","phase":"PHASE4","title":"Use of CXCL9 as a Biomarker of Acthar Efficacy","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2022-11-03","conditions":"Sarcoidosis","enrollment":14},{"nctId":"NCT01838174","phase":"PHASE4","title":"A Trial of Neuroprotection With ACTH in Acute Optic Neuritis","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2013-05","conditions":"Multiple Sclerosis","enrollment":37},{"nctId":"NCT05826080","phase":"","title":"Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism","status":"UNKNOWN","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2021-09-01","conditions":"Primary Aldosteronism, Aldosterone-Producing Adenoma, Idiopathic Hyperaldosteronism","enrollment":59},{"nctId":"NCT03320070","phase":"PHASE4","title":"Acthar Gel in Participants With Pulmonary Sarcoidosis","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2018-02-21","conditions":"Sarcoidosis, Pulmonary","enrollment":55},{"nctId":"NCT05648526","phase":"NA","title":"Neuroprotective Effects of ACTH4-10PRO8-GLY9-PRO10","status":"COMPLETED","sponsor":"Universitas Sumatera Utara","startDate":"2021-08-01","conditions":"Ketamine-Induced Neurotoxicity","enrollment":42},{"nctId":"NCT04374721","phase":"NA","title":"Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2018-07-04","conditions":"Cushing Syndrome, Adrenal Insufficiency, Cushing Disease","enrollment":44},{"nctId":"NCT05546047","phase":"PHASE4","title":"A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients","status":"UNKNOWN","sponsor":"NephroNet, Inc.","startDate":"2019-03-14","conditions":"Fibrillary Glomerulonephritis","enrollment":34},{"nctId":"NCT02546492","phase":"PHASE4","title":"Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2016-08","conditions":"Transplant Glomerulopathy","enrollment":6},{"nctId":"NCT04080076","phase":"PHASE4","title":"Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy","status":"WITHDRAWN","sponsor":"NephroNet, Inc.","startDate":"2019-01-12","conditions":"Renal Disease","enrollment":""},{"nctId":"NCT03025828","phase":"PHASE4","title":"Adrenocorticotropic Hormone in Membranous Nephropathy","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2018-03-19","conditions":"Membranous Nephropathy","enrollment":5},{"nctId":"NCT03414086","phase":"","title":"Predictor of Clinical Response to Acthar in Myositis","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2017-11-06","conditions":"Myositis, Dermatomyositis, Polymyositis","enrollment":20},{"nctId":"NCT05488704","phase":"","title":"The Effect of Nonstress Test Device Noise Level on Stress Parameters in Primiparous Pregnant Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"Halic University","startDate":"2021-02-01","conditions":"Stress, Noise Exposure, Prenatal Stress","enrollment":44},{"nctId":"NCT02316132","phase":"NA","title":"Confocal Laser Endomicroscopy, IBS and Stress","status":"WITHDRAWN","sponsor":"University Hospital Schleswig-Holstein","startDate":"2014-12","conditions":"Irritable Bowel Syndrome","enrollment":""},{"nctId":"NCT01960530","phase":"PHASE1","title":"An Investigational Study of Hydrocortisone","status":"COMPLETED","sponsor":"Neurocrine UK Limited","startDate":"2013-10","conditions":"Adrenal Insufficiency","enrollment":14},{"nctId":"NCT04833192","phase":"","title":"Evaluation of New Diagnostic Indicator of Subclinical Hypercortisolism","status":"UNKNOWN","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2020-04-01","conditions":"Adrenal Incidentaloma, Subclinical Hypercortisolism","enrollment":202},{"nctId":"NCT01764711","phase":"NA","title":"Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2013-01","conditions":"Postural Tachycardia Syndrome","enrollment":13},{"nctId":"NCT03368066","phase":"PHASE3","title":"Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2018-01-29","conditions":"Adrenal Insufficiency, Cirrhosis, Spur Cell Anemia","enrollment":100},{"nctId":"NCT03419650","phase":"PHASE4","title":"Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)","status":"COMPLETED","sponsor":"IRIS Research and Development, LLC","startDate":"2018-07-20","conditions":"Psoriatic Arthritis","enrollment":10},{"nctId":"NCT02399462","phase":"PHASE4","title":"Acthar for Treatment of Post-transplant FSGS","status":"WITHDRAWN","sponsor":"University of North Carolina, Chapel Hill","startDate":"2021-03","conditions":"FSGS, Renal Transplantation, Kidney Transplantation","enrollment":""},{"nctId":"NCT04169061","phase":"PHASE4","title":"Impact of Acthar on Everyday Life of Participants With Severe Keratitis","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2019-11-13","conditions":"Keratitis","enrollment":36},{"nctId":"NCT02633046","phase":"PHASE4","title":"Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria","status":"COMPLETED","sponsor":"Mallinckrodt ARD LLC","startDate":"2016-10-10","conditions":"Idiopathic Focal Segmental Glomerulosclerosis","enrollment":63},{"nctId":"NCT03656692","phase":"PHASE4","title":"Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)","status":"TERMINATED","sponsor":"Mallinckrodt","startDate":"2018-10-05","conditions":"Uveitis, Posterior, Uveitis, Intermediate, Panuveitis","enrollment":5},{"nctId":"NCT03126760","phase":"PHASE4","title":"Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)","status":"TERMINATED","sponsor":"Mallinckrodt ARD LLC","startDate":"2017-05-22","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":35},{"nctId":"NCT02749227","phase":"PHASE2","title":"Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors","status":"TERMINATED","sponsor":"Columbia University","startDate":"2017-07-10","conditions":"Pituitary Tumor, ACTH-producing Pituitary Tumour","enrollment":4},{"nctId":"NCT02298491","phase":"PHASE4","title":"CNS Sarcoidosis and Acthar Gel","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2016-05","conditions":"CNS Sarcoidosis","enrollment":4},{"nctId":"NCT04808856","phase":"NA","title":"Treatment of Refractory Gout With ACTH or Methylprednisolone","status":"UNKNOWN","sponsor":"Shanghai 10th People's Hospital","startDate":"2021-04-01","conditions":"Gout","enrollment":60},{"nctId":"NCT03400852","phase":"PHASE2","title":"A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy","status":"TERMINATED","sponsor":"Mallinckrodt ARD LLC","startDate":"2018-07-27","conditions":"Muscular Dystrophy, Duchenne","enrollment":44},{"nctId":"NCT03042637","phase":"","title":"Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome","status":"SUSPENDED","sponsor":"Southeast Renal Research Institute","startDate":"2012-01","conditions":"Nephrotic Syndrome","enrollment":""},{"nctId":"NCT03287635","phase":"PHASE4","title":"Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Toyos Clinic","startDate":"2018-07-01","conditions":"Dry Eye Disease","enrollment":19},{"nctId":"NCT01331239","phase":"PHASE2","title":"Safety and Efficacy of LCI699 in Cushing's Disease Patients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-03-23","conditions":"Cushings Disease, Cushing Disease","enrollment":31},{"nctId":"NCT02446886","phase":"PHASE4","title":"Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2016-06","conditions":"Multiple Sclerosis","enrollment":15},{"nctId":"NCT01984268","phase":"PHASE2","title":"ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate","status":"TERMINATED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2014-06-23","conditions":"Rheumatoid Arthritis","enrollment":15},{"nctId":"NCT00196001","phase":"","title":"Adrenocorticotropic Hormone (ACTH) Stimulation and G Protein","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2005-07","conditions":"Adrenal Sufficiency","enrollment":35},{"nctId":"NCT00986960","phase":"PHASE2","title":"Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)","status":"WITHDRAWN","sponsor":"University at Buffalo","startDate":"2009-12","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT02920710","phase":"PHASE4","title":"ACTHAR Therapy for Central Nervous System Sarcoidosis","status":"WITHDRAWN","sponsor":"The Cleveland Clinic","startDate":"2019-02-01","conditions":"Sarcoidosis","enrollment":""},{"nctId":"NCT03302416","phase":"EARLY_PHASE1","title":"CRF - Nociceptin Receptor Interactions","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2016-06-01","conditions":"Healthy","enrollment":19},{"nctId":"NCT03068754","phase":"PHASE2, PHASE3","title":"Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)","status":"TERMINATED","sponsor":"Mallinckrodt","startDate":"2017-06-22","conditions":"Amyotrophic Lateral Sclerosis","enrollment":143},{"nctId":"NCT01915303","phase":"PHASE2","title":"Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2014-03-06","conditions":"Cushings Disease","enrollment":68},{"nctId":"NCT02057523","phase":"PHASE4","title":"Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients","status":"TERMINATED","sponsor":"University of Illinois at Chicago","startDate":"2014-09","conditions":"Proteinuria, Transplant Glomerulopathy","enrollment":2},{"nctId":"NCT02258217","phase":"NA","title":"Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)","status":"COMPLETED","sponsor":"OhioHealth","startDate":"2014-06","conditions":"Relapsing Remitting Multiple Sclerosis","enrollment":30},{"nctId":"NCT02953821","phase":"PHASE4","title":"Acthar Gel for Active Systemic Lupus Erythematosus (SLE)","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2016-12-16","conditions":"Lupus Erythematosus, Systemic","enrollment":172},{"nctId":"NCT00851942","phase":"PHASE4","title":"Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test","status":"COMPLETED","sponsor":"Cardiff University","startDate":"2008-09","conditions":"Healthy, Adrenal Insufficiency, Hypopituitarism","enrollment":165},{"nctId":"NCT03613129","phase":"PHASE1, PHASE2","title":"Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome","status":"COMPLETED","sponsor":"LUCINDA BATEMAN, MD","startDate":"2018-07-23","conditions":"Myalgic Encephalomyelitis, Chronic Fatigue Syndrome","enrollment":17}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2375,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ACTH"],"phase":"phase_3","status":"active","brandName":"Adrenocorticotrophic hormone","genericName":"Adrenocorticotrophic hormone","companyName":"University of Ottawa","companyId":"university-of-ottawa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Adrenocorticotrophic hormone (ACTH) stimulates the adrenal cortex to produce and release cortisol and other corticosteroids. Used for Adrenocortical insufficiency, Infantile spasms (West syndrome), Autoimmune and inflammatory conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}